FTC paus­es chal­lenge of Am­gen's $28B Hori­zon takeover to con­sid­er set­tle­ment

The FTC is paus­ing its chal­lenge of Am­gen’s pro­posed $28 bil­lion buy­out of Hori­zon Ther­a­peu­tics for sev­er­al weeks to ex­plore al­ter­na­tive ways of re­solv­ing the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER